Healthcare & Biotech - Watch India! The Next Healthcare & Biotech Frontier
The convergence of talent, low costs, and strong R&D capabilities positions India as a hot destination for biotech investment. This panel will explore some of the latest trends in India's healthcare and biotech industries, including the changing landscape of patent protection and U.S. FDA approval of manufacturing facilities. From entrepreneurship at Medsphere to building the Dr. Reddy's healthcare colossus in India - this panel looks to span the gamut of opportunity in India's healthcare and biotech space. With an average life expectancy of 64 years (as opposed to 74 years in the US) and almost 4 million people living with HIV/AIDS, the Indian healthcare story is as much about fulfilling a burning need as taking advantage of a blinding opportunity.
G.V.Prasad, CEO, Dr Reddy's
Joe Shrawder, General Manager,
GE Diagnostic Imaging Performance Technologies
Hooman Bahmandeji, President,
Khurana , Director, PRTM
Ravindran , Principal, Radius Ventures, LLC.
Amit M. Patel, Vice-President, Corporate Development & Strategic Planning, Dr.Reddy's
- Reaching One Billion Consumers
The emerging organized retail sector in India has drawn huge interest from players all over the globe. A boom in consumerism fueled by the fastest growing middle-class population in the world has seen India named the No. 1 Retail destination in a well-known management consulting firm’s most recent Global Retail Development Index. This panel will explore the opportunities for Foreign Direct Investment within the sector as well as relevant market priorities for global retailers.
Kohli, Partner, McKinsey & Company
C K Venkataraman, COO, Tanishq
N V Sivakumar, Executive Director, PWC
D Shivakumar, VP and General Manager, Nokia India
Prof. Sunil Chopra, Senior Associate Dean, Kellogg School of Management
Entrepreneurship & Venture Capital - The Next Big Idea
As one of the fastest growing industries within one of the world's fastest growing democracies, Venture Capital has moved from a mere 1% of overall corporate buyout activity into the double digits in 2006. The explosion of LBO funds excelling in the Indian markets has paved the way for sustained growth in foreign investment. This panel explores the various players in this relatively new industry, the exit strategies that are becoming relevant and the returns that make it a lucrative business to enter. It also focuses on the demand side of the market and highlights the talented entrepreneurs looking for funding and the issues they face in accessing capital. As quoted by a principal from one of the leading investment firms in India - "It's about enlarging the pie, not just slicing up what's already there."
Mohan Warrior, President & CEO, Alfalight
Jai Shekhawat, CEO & Co-Founder, Fieldglass
Sunil Gaitonde, CEO, GS-Lab
Matt McCall, Co-Founder & Managing Director, Portage Venture Partners
Prof. Ranjay Gulati, Professor, Kellogg School of Management
Real Estate - Too Good to Be True?
For investors seeking the high returns no longer possible in the mature European and North American real estate markets, India has become the destination of choice. While it is still a fragmented industry with high transaction costs, changing government policies are whetting the appetites of foreign investors as demand for housing developments, malls and office buildings has skyrocketed. But can this phenomenal growth continue? This panel focuses on this emerging sector and the opportunities and challenges within.
Priyaranjan Kumar, Director, Cushman & Wakefield
Douglas Smith, Principal, HOK
Bhargav Sri Prakash, Founder & CEO, CADcorporation
Kunal Banerji, Vice President - Marketing & Corporate Communications, Ansal API
Prof. Kathleen Hagerty, Senior Associate Dean, Kellogg School of Management
Students and Faculty - $15
Students - $25
Kellogg Alumni - $60
Corporate - $125
Online registration CLOSED.
If you are still interested in attending, walk-in registrations will be available on the day of the event on a first-come-first-serve basis.